🔎 Trials Near Me

Gara Jalqabaatti › COPD › Nevada › Las Vegas

Qorannoo klinikaalii COPD Las Vegas, NV keessatti

Qorannoo 6 COPD f Las Vegas fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Namoota walitti qabaa jiraSadarkaa 3
  • GSK Investigational Site, Las Vegas
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06961214

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

Namoota walitti qabaa jiraSadarkaa 3
  • GSK Investigational Site, Las Vegas
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06959095

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Las Vegas
  • Research Site, Las Vegas
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Namoota walitti qabaa jiraSadarkaa 3
  • Excel Clinical Research - Las Vegas- Site Number : 8400070, Las Vegas
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07190222

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Las Vegas
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06883305

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Namoota walitti qabaa jiraSadarkaa 3
  • GSK Investigational Site, Las Vegas
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07177339

Qorannoo COPD magaalota biroo keessatti

Qorannoo biroo Las Vegas keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.